ClinicalTrials.gg
CompletedNCT05499221Updated Jul 9, 2024

Bone Anchored Carriere Motion Appliance

An interventional study of Carriere motion appliance in Malocclusion, Angle Class II, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 11 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-09.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Jun 2023, 3 years 4 months ago, and no results have been posted to the registry.
  • Registered 6 months after the study started (first participant enrolled Jan 2022, registered Aug 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
11 Years to 16 Years
Sex
All
01

Study summary

Carriere Motion appliance (CMA) was designed to change a Class II molar relationship into a Class I relationship by distalizing the whole posterior maxillary segment by means of class II elastics and mandibular anchorage. To eliminate the adverse effects of CMA with class II elastics, we can use the CMA to distalize the maxillary posterior segment with intra-arch anchorage using infrazygomatic miniscrews. The aim of this study is to evaluate skeletaly anchored CMA for distalization of the maxillary buccal segment vs. conventionally anchored CMA by comparing skeletal and dental measurements obtained from lateral cephalometric radiographs obtained prior to treatment (T0) and immediately after correction of class II and remval of the appliance (T1).

Read the detailed description

Thirty-two class II malocclusion patients with age (11-16) years will be randomly allocated in the two groups:

  1. Conventional anchorage CMA group (CAG): conventional mandibular anchorage using Essix retainer.
  2. Skeletal anchorage CMA group (SAG): anchorage by infra-zygomatic miniscrews. In the CAG, Class II elastics will be attached from the maxillary canine to the mandibular first molar bilaterally with Essix retainer in the lower arch as anchorage means. In the SAG, closing coil spring will be attached from the maxillary canine to the infrazygomatic miniscrews bilaterally. For each patient, two lateral cephalograms will be obtained: one preoperatively and another after completion of distalization. Model measurements will be made using the attached 3Shape computer software.
02

Conditions studied

  • Malocclusion, Angle Class II

Keywords

  • Carriere motion appliance
  • Distalization
  • Skeletal anchorage
  • Infrazygomatic miniscrews
03

In context

Malocclusion, Angle Class II

124 studies on the registry are indexed under Malocclusion, Angle Class II; 19 are open to participants now.

This study's enrollment of 32 is close to the median of 34 across 115 interventional studies indexed under Malocclusion, Angle Class II.

Browse Malocclusion, Angle Class II studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients age (11-16) years.
  2. Full permanent dentition.
  3. Class II malocclusion with at least an end-on Class II molar relationship bilaterally.

Exclusion criteria

Exclusion Criteria:

  1. Systemic conditions that may interfere with the treatment.
  2. Bad habits that might jeopardize the appliance.
  3. Transverse discrepancy.
  4. Previous orthodontic treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Conventional anchorage

    Buccal tubes will be bonded on the lower first molars, an alginate impression will be taken for the lower arch with the buccal tubes in place, and a cast will be poured. A hard vacuum sheet of 1.5- mm thickness will be used to fabricate the Essix appliance. The posterior end of the buccal surface will be trimmed in each lower first molar region, creating a window to allow for attachment of the elastics. Class II elastics will be attached from the maxillary canine to the mandibular first molar bilaterally. During the first month, 1/4-inch heavy elastics will be used. In the following months, 3/16-inch heavy elastics will be used. The patients will be instructed to wear the elastics 24 hours per day, except during mealtimes, and to change them daily.

    Device: Carriere motion appliance

  • Experimental
    Skeletal anchorage

    Closing coil springs will be attached from the maxillary canine to the infrazygomatic miniscrews bilaterally

    Device: Carriere motion appliance

Interventions

  • DeviceCarriere motion appliance

    The CMA will be bonded on the permanent maxillary canine and first molar, and the correct size is chosen according to the manufacturer's instructions.

06

What researchers measure

Primary outcomes

  1. Treatment duration

    months

    Time frame: from date of appliance delivery to date of removal after reaching class I molar relationship (about 4-6 months)

  2. Skeletal changes

    degrees

    Time frame: from date of appliance delivery to date of removal after reaching class I molar relationship (about 4-6 months)

  3. Dental changes

    degrees

    Time frame: from date of appliance delivery to date of removal after reaching class I molar relationship (about 4-6 months)

07

Study locations

1 site
  • MansouraU, faculty of dentistry, orthodontics department
    Mansoura, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2022 to primary completion in Jun 2023, 17 months.

Of 86 non-industry interventional studies with no phase under Malocclusion, Angle Class II, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 22. This study's 17 months is above that.

Counting every sponsor, half of 86 studies reached it within 15 months; a quarter within 11 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2022
First posted
Aug 12, 2022
StartActual
Jan 26, 2022
Primary completionActual
Jun 26, 2023
CompletionActual
Aug 26, 2023
Last update
Jul 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05499221
Responsible party
Eglal Ahmed (Dr., Mansoura University) — Principal investigator
First posted
Aug 12, 2022
Start date
Jan 26, 2022
Primary completion
Jun 26, 2023
Completion
Aug 26, 2023
Last update
Jul 9, 2024

Study contacts

Eglal A. Ghozy, BDS, MDS
principal investigator · Mansoura University
Ahmed A. El-bialy, PhD
study chair · Mansoura University
Marwa S. Shamaa, PhD
study director · Mansoura University
Nehal F. Albelasy, PhD
study director · Mansoura University

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion